Jonathan Steckbeck, PhD, MBA
CEO & Founder
Dr. Jonathan Steckbeck brings deep scientific and business expertise to Peptilogics, combining a background in biochemistry and molecular genetics with strategic leadership and company-building.
He has led the company’s funding and growth from inception and platform development through advancement to pivotal trials for its lead anti-biofilm therapeutic targeting high unmet needs across disease areas.
Dr. Steckbeck earned his PhD in Biochemistry and Molecular Genetics and an MBA from the University of Pittsburgh.